Mangoceuticals (MGRX) Total Debt (2022 - 2026)

Mangoceuticals has disclosed Total Debt across 4 years of filings, most recently posting $89888.0 for Q2 2026.

• In Q2 2026, Total Debt fell 82.02% year-over-year to $89888.0; the TTM figure through Jun 2026 stood at $89888.0 (down 82.02% YoY), while the FY2024 annual figure was $150000.0, changed N/A from the prior year.
• Total Debt came in at $89888.0 for Q2 2026 at Mangoceuticals, down from $100000.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $500000.0 in Q2 2025 to a low of $87500.0 in Q1 2024.
• Average Total Debt over 4 years is $183731.0, with a median of $158730.0 recorded in 2022.
• Year-over-year, Total Debt soared 166.67% in 2025 and sank 82.02% in 2026.
• Over 4 years, Total Debt stood at $167460.0 in 2022, then retreated by 10.43% to $150000.0 in 2024, then slumped by 33.33% to $100000.0 in 2025, then dropped by 10.11% to $89888.0 in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $89888.0 in Q2 2026, $100000.0 in Q3 2025, and $500000.0 in Q2 2025.